AnalytiCon, a new executive conference launching October 13-15, 2026, will bring life sciences leaders to Boston to discuss how AI and analytics are transforming research, clinical development, and commercial strategy.

AnalytiCon invites senior leaders from pharmaceutical, biotechnology, and medical device organizations to join experts in AI, analytics, and digital transformation for two days of focused discussion on how organizations turn data into measurable business and scientific impact.

The inaugural conference will feature keynote speaker James Sun, an entrepreneur and investor who has led over 100 AI implementations for private equity-backed companies. James will explore the frontier of decision intelligence: AI systems that learn to reason through the messy, context-dependent choices that drive real business results. According to James, “the future belongs to organizations that build decision engines reflecting their own unique logic.”

Based in the MIT innovation ecosystem, Sun collaborates with PhD researchers in AI and data science to study how artificial intelligence can move beyond probabilistic prediction toward genuine reasoning and judgment. Sun is known for hosting the BBC series Sun Tzu: War on Business, for his appearance on The Apprentice, and for holding roles at Intel and Deloitte.

Conference Themes Address AI’s Real-World Impact

Conference programming will focus on several core themes that address how life sciences organizations operationalize AI and analytics.

Analytics Strategy, Data Governance, and Measuring ROI on AI Investment will address how organizations create value through effective governance, investment choices, and responsible data practices.

Embedding AI, Machine Learning, Generative, and Agentic Models into Real-World Workflows will discuss the integration of advanced technologies into analytics functions across the R&D, clinical, and commercial lifecycle.

Applied AI Analytics from R&D to Commercial Strategy will highlight how analytics inform oncology research, drug discovery, clinical trial recruitment, real-world evidence, healthcare engagement, brand planning, and forecasting.

Program Highlight: The AI Analytics Challenge

A signature feature of AnalytiCon, the AI Analytics Challenge, invites attendees to engage in an interactive, hands-on experience that moves beyond theory to practical application.

Participants will collaborate in teams using realistic datasets based on life sciences scenarios. Guided by industry experts, teams will work through the full analytics process, from framing the business case and selecting the appropriate technology stack to building models and presenting data-driven insights.

Register now and explore program details and sponsorship opportunities at AnalytiCon.AI to secure your place at the forefront of AI-driven analytics in life sciences.

About AnalytiCon

AnalytiCon brings together leaders in life sciences, artificial intelligence, and advanced analytics to explore how data-driven technologies transform R&D, clinical, commercialization, and healthcare delivery. The conference unites executives, technologists, and innovators to share practical insights and collaborate on the next generation of AI-enabled decision-making.